Get started
Author

Dennis W. Juma

Observed names: Dennis W. Juma, Dennis Juma, Dennis W Juma, Juma, Dennis, Juma, Dennis W.
ORCID: 0000-0003-4775-8532
Observed ORCID: 0000-0003-4775-8532
OpenAlex ID: A5074945505
The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008–2011
2013 · Fredrick L. Eyase, Hoseah M. Akala, et al. · PLoS ONE · 100
PDF
Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study
2021 · Hoseah M Akala, Oliver J Watson, et al. · The Lancet Microbe · 55
PDF
Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya
2015 · Angela O. Achieng, Peninah Muiruri, et al. · International Journal for Parasitology Drugs and Drug Resistance · 55
PDF
Sample-ready multiplex qPCR assay for detection of malaria
2014 · Edwin Kamau, Saba Alemayehu, et al. · Malaria Journal · 37
PDF
Analysis of Major Genome Loci Underlying Artemisinin Resistance and pfmdr1 Copy Number in pre- and post-ACTs in Western Kenya
2015 · Bidii S. Ngalah, Luiser A. Ingasia, et al. · Scientific Reports · 34
PDF
Polymorphisms in Pf mdr1 , Pf crt , and Pf nhe1 Genes Are Associated with Reduced In Vitro Activities of Quinine in Plasmodium falciparum Isolates from Western Kenya
2014 · Jelagat Cheruiyot, Luicer A. Ingasia, et al. · Antimicrobial Agents and Chemotherapy · 33
Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
2014 · Dennis W Juma, Angela A Omondi, et al. · Malaria Journal · 29
PDF
The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis
2019 · Dennis W. Juma, Peninah Muiruri, et al. · PLoS neglected tropical diseases · 27
PDF
Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets
2017 · Reagan M. Mogire, Hoseah M. Akala, et al. · PLoS ONE · 25
PDF
Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs
2022 · Dancan M. Wakoli, Bartholomew N. Ondigo, et al. · BMC Medicine · 19
PDF
Epidemiological and clinical implications of asymptomatic malaria and schistosomiasis co-infections in a rural community in western Kenya
2021 · Edwin Kamau, Adam Yates, et al. · BMC Infectious Diseases · 19
PDF
Reduced In Vitro Doxycycline Susceptibility in Plasmodium falciparum Field Isolates from Kenya Is Associated with PfTetQ KYNNNN Sequence Polymorphism
2014 · Angela O. Achieng, Luiser A. Ingasia, et al. · Antimicrobial Agents and Chemotherapy · 18
Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population
2022 · Ben Andagalu, Oliver J Watson, et al. · Clinical Infectious Diseases · 17
PDF
A seven-year surveillance of epidemiology of malaria reveals travel and gender are the key drivers of dispersion of drug resistant genotypes in Kenya
2020 · Moureen Maraka, Hoseah M. Akala, et al. · PeerJ · 15
Burden of malaria infection among individuals of varied blood groups in Kenya
2022 · Redemptah Yeda, Charles Okudo, et al. · Malaria Journal · 12
PDF
Synergism in Antiplasmodial Activities of Artemether and Lumefantrine in Combination with Securidaca longipedunculata Fresen (Polygalaceae)
2021 · Douglas O. Ochora, Esezah K. Kakudidi, et al. · Plants · 11
PDF
Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum
2024 · Reagan M. Mogire, Silviane A. Miruka, et al. · Journal of Cheminformatics · 7
Isoliensinine from Cissampelos pariera rhizomes exhibits potential gametocytocidal and anti-malarial activities against Plasmodium falciparum clinical isolates
2023 · Jackson M. Muema, James M. Mutunga, et al. · Malaria Journal · 7
PDF
Genetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum Parasites
2016 · Lorna J. Chebon, Bidii S. Ngalah, et al. · PLoS ONE · 7
PDF
Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions
2014 · Hosea Akala, Angela Omondi, et al. · Journal of Multidisciplinary Healthcare · 7
PDF
Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria
2024 · Winnie Okore, Collins Ouma, et al. · PLoS ONE · 6
Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study
2024 · Valentin Joste, Romain Coppée, et al. · The Lancet Microbe · 6
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya
2023 · Gladys C. Chemwor, Ben M. Andagalu, et al. · International Journal of Infectious Diseases · 5
Age-dependent antibody profiles to plasmodium antigens are differentially associated with two artemisinin combination therapy outcomes in high transmission setting
2022 · Ben Andagalu, Pinyi Lu, et al. · Frontiers in Medicine · 5
PDF
Detection of Twenty-Four Plasmodium Falciparum Kelch 13 Mutations Including C469Y, P553L, R561H, and A675V Across Kenya
2024 · Hoseah Akala, Benjamin Opot, et al. · SSRN Electronic Journal · 3
Works count: 65
Citation count: 571
H-index: 14
I10-index: 16
Year
Topic
Type